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Matrix metalloproteinases (MMPs) play a crucial role in carci-
noma invasion (Ossowski, 1992), metastasis (Liotta et al, 1991;
Kim et al, 1998), angiogenesis (Brooks et al, 1998), and tumor-
igenicity (Wilson et al, 1997; Masson et al, 1998). MMP-1 is
called interstitial collagenase because of the efficient degradation
of interstitial collagen mainly composed of type I, II and III
collagen (Woessner, 1991). The spread of carcinoma cells was
demonstrated to correlate with the lysis of type I collagen, which
is the principal component of connective tissues at most body
sites, in colorectal carcinoma (van der Stappen et al, 1990) and
head and neck carcinoma (Burman and Carter, 1985). Ossowski
(1992) also revealed that invasion of connective tissue by carci-
noma cells particularly required MMP-1. MMP-1 thus appears to
be involved in carcinoma invasion. On the other hand, type IV
collagenolytic activity, which is known to be associated with the
disruption of basement membrane, plays a very important role in
the distant metastatic potential of carcinoma cells (Liotta et al,
1980). MMP-1 could, however, hardly degrade type IV collagen,
which indicates that MMP-1 is not closely involved in penetration
of vessels. Therefore MMP-1 may not be directly associated with
distant metastatic potential. Moreover, MMP-2 and MMP-9,
which are called type IV collagenase due to the efficient degrada-
tion of type IV collagen, is less able to degrade interstitial
collagen (Woessner, 1991). These findings suggest that carci-
noma invasion and metastasis are somewhat independent
processes. 
Murray et al claimed that MMP-1 immunolocalized in carci-
noma cells could be associated with a poor prognosis in
colorectal (Murray et al, 1996) and oesophageal carcinoma
(Murray et al, 1998b). However, their investigation of
oesophageal carcinoma included 19 cases of squamous cell carci-
noma and only 3 cases (16%) which expressed MMP-1. In Japan,
oesophageal carcinoma consists largely of squamous cell carci-
noma and Shima et al (Shima et al, 1992) demonstrated that
oesophageal squamous cell carcinoma showed a positive correla-
tion with the depth of invasion, lymph node metastasis, and
vessel permeation regarding MMP-2 and MMP-3 expression, but
not MMP-1. However, the presence of protein does not neces-
sarily reflect the net function, and recent studies have shown
mRNA (e.g. MT1-MMP mRNA) to possibly reflect the net func-
tion (activated MMP-2) in clinical carcinoma tissue (Mori et al,
1997; Yoshizaki et al, 1997). We thus investigated MMP-1
mRNA expression of oesophageal carcinoma, which was mainly
composed of squamous cell carcinoma, in order to clarify the
significance of MMP-1. 
MATERIALS AND METHODS 
Patients and sample collection 
51 oesophageal carcinomas and their paired normal mucosa from
patients who underwent surgery at the Medical Institute of
Bioregulation Hospital, Kyushu University and the Saitama
Cancer Center had MMP-1 mRNA levels assessed. All patients
had undergone resection of the primary carcinoma, and none had
received chemotherapy or radiotherapy. The patients included 45
males and 6 females. The tumour was located either in the upper
oesophagus (n = 3), the middle oesophagus (n = 36), or the lower
oesophagus (n = 12). Twelve tumours were well differentiated, 25
were moderately differentiated, and 12 were poorly differentiated
squamous cell carcinomas. Other types of carcinoma included one
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sion of the tumour was as follows, 5 involved the submucosa, 7
involved the muscularis propria, and 39 involved the adventitia or
more. The cases with lymph node metastases were classified into
two groups: the non-metastatic group (n = 8) and metastatic group
(n = 43). Carcinoma specimens were obtained from the tumour
edge, avoiding a necrotic centre and corresponding distant normal
mucosa specimens were also obtained at least 5 cm away from the
tumour edge by sharply dissecting the mucosa off the muscularis
propria. All specimens were quick-frozen in liquid nitrogen and
stored at 280˚C until processing. 
When obtaining the tumour tissue from the surgical specimens,
we have carefully chosen the area where abundant tumour cells
seemed to be contained. The cut surface of the tumour centre
indicate the whitish area where usually contain a lot of tumour
cells. Moreover we reviewed the specimens histologically, and
almost all specimens (47/51) were ascertained that more than 80%
area contained tumour cells and the remaining 4 showed that
tumour cells occupied more than 70%. Thus we think the used
specimens were good for the molecular analysis. 
RNA extraction, reverse transcription-polymerase chain
reaction (RT-PCR) and Northern blot hybridization 
Total RNA isolation 
Frozen-tissue specimens were homogenized in guanidium thio-
cyanate and total RNAs were obtained by ultracentrifugation
through a cesium chloride cushion as described previously (Mori
et al, 1993; Yamashita et al, 2000). 
cDNA preparation and RT-PCR 
Eight µg of each total RNA was reverse-transcribed with M-MLV
reverse transcriptase (GIBCO BRL Inc., Rockville, MD), and one-
hundredths of the products were amplified by PCR according to
the following manner as previously reported (Mori et al, 1997).
The oligonucleotide primer pairs for MMP-1 were purchased from
Amersham Pharmacia Biotech UK Incorporation (Little Chalfont,
UK) (sense MMP-1, 5'-TCGCTGGGAGCAAACACATC-3'; anti-
sense MMP-1, 5'-TTCATGAGCCGCAACACGAT-3’). It was
carried out in a 30 µl volume containing cDNA template, 10 pmol
each of oligodeoxynucleotide primer, 200 mM each of deoxynu-
cleotide triphosphate, 200 mM deoxycytidine triphosphate
labelled with a-32P, PCR buffer with 1.5 mM magnesium chloride
(Perkin Elmer Cetus, Norwalk, CT), and 1.5 U of Taq polymerase
(Perkin Elmer Cetus, Norwalk, CT). The samples were overlaid
with mineral oil and processed through 24 cycles consisting of 1
min at 95˚C (denaturation), 1 min at 56˚C (annealing), 1 min at
72˚C (elongation). The same aliquots of the amplified DNA by
PCR reaction were mixed with formamide gel loading buffer and
then were electrophoresed on 5% polyacryl amide gels. The gels
were dried, and exposed to an imaging plate. The samples were
then quantitated using a Bio-Image analyzer BAS 1000 (Fuji
Photo Inc., Tokyo, Japan). The mRNA expression in tumour (T)
and normal (N) tissue in each pair was estimated on the basis of the
counts obtained. The tumour/normal ratio (T/N ratio) of MMP-1
was calculated with or without correcting for the GAPDH expres-
sion in the following manner: T/Nraw = MMP-1 (T) / MMP-1 (N),
T/Nc (T/N in the following text) = (MMP-1 (T) / GAPDH (T)) /
(MMP-1 (N) / GAPDH (N)). PCR products were ligated into pCR
2.1 vector (In Vitrogen Inc. Carlsbad, CA) and sequencing
confirmed MMP-1 using DNA sequencing kit-Dye terminator
cycle sequencing ready reaction (Perkin Elmer Applied
Biosystems Inc., Foster, CA). To validate the quantitative analysis
for MMP-1 expression using our RT-PCR method, the radioac-
tivity for MMP-1 were examined based on varying numbers of
PCR cycles and serial dilutions of RNA samples. Figure 1 showed
the radioactivity values to increase linearly at 24 cycles and also
showed a correlation with the RNA contents. These findings thus
indicated a quantitative assessment in this assay for MMP-1. The
appropriate cycle for glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was determined according to the previously described
method (Mori et al, 1997). 
Northern blot hybridization 
Equal amounts  (15 mg) of total RNA were loaded and analysed as
previously described (Mimori et al, 1996). The fold-increase of
MMP-1 in each tumour tissue specimen relative to its corre-
sponding adjacent normal tissue specimen was calculated after
correcting for the GAPDH expression. MMP-1 probe was kindly
conferred by Professor Barry L. Marmer, Division of
Dermatology, School of Medicine, Washington University. 
Gelatin zymography 
SDS-PAGE and zymography using gelatin containing gel for
detecting gelatinolytic activities were performed in 17 cases
following the procedures reported previously (Mori et al, 1997).
Briefly, each specimen was homogenized in a sample buffer
containing 10 mM Tris/HCl, pH 6.8, 20% glycerin, 2% SDS, and
0.1% bromophenol blue. The samples were separated by elec-
trophoresis on 10% polyacrylamide gel containing 0.1% SDS and
1 mg ml-1 gelatin as a substrate. The gels were then washed in the
renaturation buffer (50 mM Tris/HCl, pH 7.5, 0.1 M NaCl)
containing 2.5% Triton X-100 for 90 minutes. Thereafter the gels
were incubated for 18 hours at 37˚C in a reaction buffer (50 mM
Tris/HCl, pH 7.5, 10 mM CaCl2) and stained with 0.1% Coomassie
Brilliant blue R250. 
Western blot analysis 
Total protein was extracted from clinical samples (n = 10) by RIPA
buffer. This same aliquots (50 µg) of total protein were applied to
10% acrylamide gradient gels. Following electrophoresis, samples
were electroblotted onto a polyvinylidene difluoride membrane
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Figure 1 (A) The radioactivity of PCR products and the number of PCR
cycles. The radioactivity increased linearly between 18 and 32 PCR cycles
for MMP-1. (B) The radioactivity of PCR products and serial dilutions of RNA
samples. The radioactivity of PCR products correlated with the RNA content 
(A) (B)(Immobilin, Millipore Inc., Bedford, MA) at 0.5 A for 1.5 hours at
4˚C. Both MMP-1 and MMP-2 were detected by the use of mouse
monoclonal primary antibodies (F-67 and F-68, respectively, Fuji
Pharmacochemical Inc., Toyama, Japan) used in an a dilution of
1:1000. The blots were developed using anti mouse immunoglob-
ulin, horseradish peroxidase liked whole antibody (Promega Inc.,
Madison, WI). Signals were detected using Supersignal (Pierce
Inc., Reckford, IL). The prestained high molecular-weight markers
were run on gels (Amersham Life Science Inc., Little Chalfont,
England). 
Immunohistochemistry 
To identify the localization of MMP-1 protein in the oesophageal
carcinoma, an immunohistochemical analysis was performed in 17
oesophageal carcinoma cases by using a previously described
method (Mori et al, 1997). Six normal oesophageal mucosas were
investigated in the same manner. Briefly, 5 micron thick sections
were cut from the formalin fixed, paraffin-embedded block.
MMP-1 was detected by the use of mouse monoclonal primary
antibody to MMP-1 (F-67, Fuji Pharmacochemical Inc., Toyama,
Japan) in a dilution of 1:100. Immunostaining was done by the
avidin-biotin-peroxidase method. 
Quantitation and statistical analysis 
Associations between the variables were tested by Student’s t test
or Fisher’s exact probability test. Survival analysis was done by
Cox-Mantel test. 
RESULTS 
MMP-1 expression at mRNA level in oesophageal
carcinoma 
Our present analysis of oesophageal carcinoma showed that
MMP-1 was almost exclusively expressed in the carcinoma tissue
specimens. RT-PCR was very sensitive and 48 carcinoma tissues
(94.1%) expressed MMP-1 mRNA in 51 patients and almost non-
expression in normal oesophageal tissues (Fig. 2). In RT-PCR, the
value of MMP-1 T/N ratio corrected for GAPDH was mean 42.5
(0.3–277.4). With respect to T/N ratio of GAPDH mRNA expres-
sion, the average was 1.3 varying from 0.5 to 2.3 in RT-PCR. To
confirm the accuracy of quantitation, we performed a Northern
blot analysis in as many specimens as we could (n = 45) and in 21
(47%) of the 45 cases, the expression of MMP-1 mRNA was
recognized in the tumour tissue, while almost no expression for
MMP-1 was recognized in the normal oesophageal tissue. T/N
ratio of MMP-1 mRNA after correction of GAPDH ranged from
0.4 to 42.6 (mean 11.5) in a Northern analysis and almost all cases
were confirmed to be equal between tumour and normal tissues
when evaluated by the staining of Etidium Bromide as shown in
Figure 2. In the range to be detected by a Northern blot analysis,
the signal intensities by RT-PCR were closely related to the corres-
ponding signals of a Northern blot analysis (R = 0.89; P < 0.001;
data not shown) (Fig. 2). 
MMP-1 mRNA and clinicopathological factors 
In a clinicopathological analysis, we established a cut off value
for the MMP-1 T/N ratio in RT-PCR analysis to determine the
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Figure 2 A Northern blot and RT-PCR analysis of MMP-1 mRNA
expression in oesophageal carcinoma tissues (T) and normal mucosal
tissues (N). In both analyses, MMP-1 mRNA is expressed exclusively in T,
but not in N. The same membranes of the top panel were stripped and
rehybridized with a probe to GAPDH as an internal control. RNA was
also visualized by the staining of Etidium Bromide and confirmed that equal
volumes were loaded in each case. At the bottom panel, T/N ratio of 
MMP-1 mRNA after normalizing GAPDH in an RT-PCR is 
represented 
Table 1 Clinicopathological characteristics as to MMP-1 mRNA expression
in oesophageal carcinoma 
MMP-1 T/N 
< 10  = > 10  P value 
(n = 23) (n = 28)
Age (y) 64.8 ± 8.4 61.1 ± 10.0 N.S. 
Sex 
Male 20 25 
Female 3 3 N.S. 
Histological differentiationa
Well 5 7 
Moderately 10 15 
Poorly 7 5 
Others 1 1 N.S. 
Location 
Upper 3 0 
Middle 14 22 
Lower 6 6 N.S. 
Depth of invasion 
Submucosa 5 0 
Muscularis propria 2 5 (P = 0.027) 
Adventitia 16 23 P < 0.05 
Vascular permeation 
Absent 5 7 
Present 18 21 N.S. 
Lymphatic permeation 
Absent 2 3 
Present 21 25 N.S. 
Lymph node metastasis 
Absent 3 5 
Present 20 23 N.S. 
Stageb
1, 2 5 3 
3, 4 18 25 N.S. 
N.S. not significant. aThis analysis included 49 squamous cell carcinoma.
Others included one basal cell carcinoma and one adenocarcinoma.
bAccording to the guidelines for clinical and pathological studies on carcinoma
of the oesophagus. (Japanese Society for Esophageal Diseases, 1976). malignant potential in each case. If a value of 10 was selected as a
cut off line, then 23 cases with T/N < 10 had 5 patients involving
the submucosa, while 28 cases with T/N ³ 10 had no such patients
(P = 0.027) (Table 1). Moreover, RT-PCR showed no expression
in only 3 carcinoma tissue specimens, 2 of which involved sub-
mucosa (P = 0.023). Namely the group with a high MMP-1
expression showed a deeper invasion than that with a low MMP-1
expression. On the other hand, there were no significant differ-
ences regarding age, sex, histologic differentiation, lymph node
metastasis, lymphatic or vascular permeation, or stage between
these two groups by RT-PCR (Table 1). 
We also established the various cut off values of the T/N ratio to
determine the malignant potentiality-contribution of prognosis in
advanced oesophageal carcinoma (Table 2). We selected as a cut-
off line is 10 as described, where the number balance between high
group (n = 18) and low group (n = 28) seemed appropriate.
Therefore, T/N ratio of 10 was chosen in the following context. In
our cases, no early stage carcinoma cases involving submucosa
died despite T/N < 10 within the observed terms probably due to
the early stage and small number of cases (n = 5). We therefore
restricted our prognostic analysis to advanced cases (n = 46)
involving the muscularis propria or more. The patients with T/N <
10 of MMP-1 showed a significantly poorer prognosis than those
with T/N ³ 10 of MMP-1, especially in advanced oesophageal
carcinoma (P = 0.0046) (Fig. 3). We also investigated the T/N ratio
of MMP-1 mRNA expression without correction by GAPDH in
RT-PCR. MMP-1 mRNA T/N ratio after GAPDH correction
caused only minor alteration of the order in each T/N ratio. In both
analyses with or without correcting for GAPDH, the groups with
high MMP-1 and low MMP-1 did not change when selecting a
T/N ratio of 10 and therefore the results as shown in Figure 3 or
Table 1 were not affected by this correction. 
In contrast, 17 of 23 cases with T/N < 10 underwent a Northern
blot analysis but MMP-1 mRNA was hardly detectable (T/N ratio
≤ 1) in all the cases. In contrast, all 28 cases with T/N ³ 10 under-
went a Northern blot analysis and 21 in all 28 cases were
detectable (T/N ratio > 1). An analysis by a Northern blot
hybridization also revealed a significant correlation with the depth
of invasion (P = 0.03), but no other significant factors were
observed (inverse tendency (P = 0.18) as to prognosis) (data not
shown). 
Gelatinolytic band at 40 and 50 kD and MMP-1 mRNA
association 
Tumour tissue specimens and normal mucosa specimens of
17 oesophageal carcinoma cases were examined in gelatin
zymography. All tumour samples showed a band at 72 kD which is
a latent MMP-2 and 15 out of 17 showed a band at 66 or 64 kD
which is an active MMP-2. The putative latent and active forms
of MMP-1 migrated at 50 and 40 kD, respectively. 50 kD
gelatinolytic band was demonstrated to be latent MMP-1 by
immunoprecipitation with MMP-1 antibodies (Ossowski, 1992;
Kim et al, 1998). All cases were evaluated at mRNA level of
MMP-1 by both RT-PCR and Northern blot hybridization.
Representative cases are shown in Figure 4A. Gelatin zymography
demonstrated the latent form (50 kD) of MMP-1 to be present in
10 tumour (56%) and no normal tissue specimens were examined.
On the other hand, the active form (40 kD) was presented in 9
(53%) tumour tissue samples and non-normal samples. Both 50
kD and 40 kD bands were closely associated with each other
(Figure 4A). The 50 kD and 40 kD bands were also significantly
associated with MMP-1 mRNA expression according to the
Northern blot analysis (data not shown). Although 6 cases with
MMP-1 containing tumours have very high MMP-2 activities,
however, 3 cases with MMP-1 containing tumours have low
MMP-2 activities as case 5 and 6 in Figure 4A, which is unlikely
to suggest MMP-2 to be required for MMP-1 activation. 
Western blot analysis 
Figure 4B showed representative bands of MMP-1 and MMP-2
corresponding to zymography in Figure 4A. In oesophageal carci-
noma tissues, MMP-1 showed 50 kD (4/10) and 40 kD (3/10)
bands and MMP-2 showed 72 (10/10), 66 (5/10), 64 (4/10), and 43
kD (1/10) bands. On the other hand, in normal oesophageal
mucosal tissues, MMP-1 showed 50 kD (2/10) and 40 kD (0/10)
bands and MMP-2 showed 72 (10/10), 66 (4/10), 64 (3/10), and 43
kD (0/10) bands. In the present analysis, there recognized no band
at 50 kD using MMP-2 antibody. 
MMP-1 protein localization by immunohistochemistry 
Six normal oesophageal mucosa samples showed weak immuno-
staining (Fig. 5A). Oesophageal carcinoma cells showed a varying
degree of immunostaining for MMP-1 (11/17: 65%) (Fig. 5C),
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Figure 3 Kaplan-Meier overall survival curves in oesophageal carcinomas
excluding the cases involving the submucosa between high (T/N fold-
increase ³ 10) and low (T/N fold-increase < 10) MMP-1 mRNA expression by
RT-PCR. The group with low MMP-1 expression showed a poorer prognosis
than that with high MMP-1 expression. The Cox’s analysis comparing the 2
groups revealed a significant difference (P = 0.0046) 
Table 2 P values and hazard ratios according to univariate Cox’s analysis
based on increasing cut-off values of MMP-1 in advanced oesophageal
carcinoma 
Cut-off line MMP-1  MMP-1 P value Hazard ratio
high (n) low (n)
1 40 6 0 3.95 
5 33 13 0.0018 3.13 
10 28 18 0.0046 2.84 
15 25 21 0.029 2.18 
20 23 23 0.067 1.83 while some (4/17: 33%) for stromal cells (Fig. 5D). Either tumour
or stromal immunostaining for MMP-1 was recognized in 13
(76%) of the 17 cases. Three in 17 showed marked eosinophil
infiltration while the eosinophil showed an intense degree of
staining for MMP-1 (Fig. 5E, F). 
DISCUSSION 
Murray et al demonstrated that MMP-1 protein immunolocalized
in carcinoma cells correlated with a poor prognosis in colorectal
(Murray et al, 1996) and oesophageal carcinoma (Murray et al,
1998b), but not in gastric carcinoma (Murray et al, 1998a).
However, in oesophageal carcinoma, the significance was minute
regarding the prognosis and this report included 19 squamous cell
carcinomas which showed only 3 cases (16%) of positive
immunostaining of MMP-1 (Murray et al, 1998b). On the other
hand, Shima et al also revealed MMP-1 protein expression in 21%
of oesophageal squamous cell carcinoma but did not show any
significant correlation with such malignant characteristics, while
MMP-2 and MMP-3 showed a significant correlation with those
characteristics (Shima et al, 1992). In contrast, in situ expression
rate of MMP-1 mRNA was demonstrated to be high (70–100%) in
various carcinoma tissues, which was concorded with our RT-PCR
result, and mainly in stromal cells such as fibroblasts (Otani et al,
1994) and eosinophils (Gray et al, 1993; Ono et al, 1997).
Discrepancies between mRNA and protein regarding the rate of
expression and in situ localization remain controversial points of
MMP-1 and so MMP-1 mRNA and protein would better be sepa-
rately discussed (Otani et al, 1994; Murray et al, 1996). 
We therefore investigated MMP-1 mRNA expression in
oesophageal carcinoma and confirmed it to be expressed exclu-
sively in almost all carcinoma tissues, but not in the normal
mucosa (Fig. 2). This suggested that MMP-1 might play a signifi-
cant role in carcinoma tissue. Three carcinoma tissues showing no
expression of MMP-1 by RT-PCR included two cases involving
submucosa (P < 0.05). Moreover, 28 cases with T/N ³ 10 did not
include any cases involving the submucosa, while 23 cases with
T/N <10 included all 5 such cases (P < 0.05) (Table 1). These find-
ings indicated that MMP-1 mRNA was correlated with the depth
of invasion in oesophageal carcinoma. MMP-1 mRNA was
demonstrated to be mainly expressed in the stromal cells not in
the tumour cells of the various carcinoma tissues including
oesophageal carcinoma (Gray et al, 1993; Otani et al, 1994). Taken
together, the early stage carcinoma stroma can be insufficient to
respond carcinoma cells and invasion of carcinoma cells through
the oesophageal wall may result from the stromal reaction against
carcinoma cells. 
Gelatin zymography revealed 50 kD and 40 kD bands and each
band was associated with MMP-1 mRNA (Fig. 4A). The identity of
50 kD gelatinolytic band was demonstrated to be latent MMP-1 by
immunoprecipitation with MMP-1 antibody (Ossowski, 1992; Kim
et al, 1998) and its band was not recognized by MMP-2 antibody in
the present study (Fig. 4B). This study also revealed MMP-1 to
show a band at 50 kD and 40 kD, which might account for the
results of gelatin zymography. Taken together, MMP-1 mRNA
might represent its net function as compared with immunohisto-
chemistry. However, MMP-1 mRNA expression inversely corre-
lated with the prognosis, especially in advanced oesophageal
carcinoma (Fig. 3, Table 2). Our results suggested MMP-1 could
affect local invasion, but not systemic dissemination in
oesophageal carcinoma. In breast carcinoma, cases with a 50 kD
gelatinolytic band was demonstrated to show a better prognosis
than the cases with no band (Remacle et al, 1996). MMP-1 might
be an inverse prognostic marker even in breast carcinoma as our
oesophageal carcinoma did. MMP-1 was dmeonstrated to be
intensely expressed in eosinophil (Ono et al, 1997; Gray et al,
1993) as our immunohistochemistry did (Fig. 5E, F) and good
carcinoma prognosis has been shown to correlate with eosinophil
infiltration (Lowe et al, 1981; Pretlow et al, 1983; Fisher et al,
1989; McGinnis et al, 1989; Sier et al, 1996). Recently, other MMP
expression derived from the host cell such as macrophages or
neutrophils was demonstrated to reflect the host defence against
carcinoma cells (Takeha et al, 1997; Migita et al, 1999). Taken
together, MMP-1 expression in eosinophils may reflect this
phenomenon. However, MMP-1 was also immunolocalized in
carcinoma cells, which suggested the prognostic significance of
MMP-1 to be unlikely to be accounted for by the host defence only. 
Our results revealed that early stage oesophageal carcinomas,
which were all T/N ratio < 10, did not include dead cases
and showed a good prognosis as reported previously in early
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Figure 4 (A) An analysis by gelatin zymography compared with MMP-1
mRNA expression in oesophageal carcinoma. The bands at 50 kD and 40 kD
were recognized and significantly associated with each other. The normal
mucosa revealed almost no these bands. Both bands were also associated
with MMP-1 mRNA. (B) Western blot analysis demonstrated bands at 50 and
40 kD for MMP-1, and those at 72 and 64 kD for MMP-2 in oesophageal
carcinoma and normal tissues. MMP-1 and MMP-2 protein are more
abundant in oesophageal carcinoma tissues as compared with its
corresponding normal mucosal tissues. As for MMP-2, the intensity of the
bands at 72 kD was strong, while the bands at 64 kD showed very weak.
These cases were identical ones shown in Figure 4A and might account for
the results of gelatin zymography oesophageal carcinoma by Sugimachi et al (1989). On the
other hand, advanced oesophageal carcinoma with a T/N ratio of
<10 showed a poorer prognosis than cases with a T/N ratio of ³10,
which suggested the different significance of early stage or
advanced carcinoma with a T/N ratio of <10. Baba et al (1993)
demonstrated that early stage oesophageal carcinoma showed an
immature form not yet infiltrated by the stromal cells. This finding
indicated that early carcinoma with a MMP-1 T/N ratio of <10
included both immature stromal state and poorly responsive
stromal one against carcinoma cells regarding MMP-1 mRNA
expression. In contrast, advanced carcinomas with MMP-1 T/N
ratio of <10 might become a mature but poorly responsive state
and such cases among advanced oesophageal carcinoma seem to
have a poor capacity of invasion and show a retarded spread of the
primary tumour. This is concorded with the previous reports that
the spread of carcinoma cells correlated with the lysis of type I
collagen in carcinoma tissues (Burman and Carter, 1985; van der
Stappen et al, 1990). Almost all advanced oesophageal carcinomas
were discovered based on the unique symptoms such as dysphasia
or hoarseness, which is thought to be determined by the primary
spread. Taken together, advanced carcinoma with a T/N ratio of
<10 could take a longer time for symptom to appear. On the other
hand, MMP-2 and MMP-9 were expressed independently from the
depth of invasion of our oesophageal carcinoma data using the
same sample (data not shown) and such MMPs expression did not
associate with MMP-1 expression in our analysis (data not shown)
and others (Brown et al, 1990; Okada et al, 1995). These results
indicated clinical oesophageal carcinoma tissues to have a
metastatic potential at early stage. 
In conclusion, MMP-1 is expressed exclusively in oesophageal
carcinoma tissues and involved in the primary spread of carcinoma
cells around the adjacent tissues at early stage. In advanced carci-
noma, however, MMP-1 did not reflect the stage of systemic
dissemination, and cases with T/N ratio < 10 seem to predict a
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Figure 5 Immunohistochemistry: (A) Normal oesophageal epithelial cells show negligible to weak immunostaining (original magnification ´ 100). (B) HE
staining of carcinoma cells invading muscular layer (original magnification ´ 400). (C) The next slide of Figure 5B showed that carcinoma cells stained positive
for MMP-1. (D) MMP-1 was also immunolocalized in stromal fibroblasts as well as carcinoma cells in 4 of 17 cases. (E) MMP-1 was expressed intensely in
infiltrated eosinophils (arrow) around the tumours (original magnification ´ 200). (F) HE staining revealed dinucleated cells with eosinophilic cytoplasm
(eosinophils) (arrow) in the next slide of Figure 5E, (original magnification ´ 400) 282 K Yamashita et al
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more advanced stage regarding the systemic dissemination as
compared with those with a T/N ratio of ³10, because cases with
T/N ratio < 10 could take a longer time for symptom to appear.
Taken together, MMP-1 could be a novel prognostic factor inde-
pendent from those previously reported in oesophageal carcinoma. 
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